FFA
IMVT icon

Farther Finance Advisors’s Immunovant IMVT Stock Holding History

Farther Finance Advisors’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$95.2K Sell
2,472
-14
-0.6% -$427 ﹤0.01% 2735
2026
Q1 		$62.4K Buy
2,486
+9
+0.4% +$233 ﹤0.01% 2842
2025
Q4 		$63K Sell
2,477
-25
-1% -$557 ﹤0.01% 2663
2025
Q3 		$40.3K Sell
2,502
-355
-12% -$5.75K ﹤0.01% 2574
2025
Q2 		$45.7K Buy
2,857
+2,855
+142,750% +$43.2K ﹤0.01% 2178
2025
Q1 		$30 Sell
2
-6
-75% -$126 ﹤0.01% 4167
2024
Q4 		$198 Hold
8
– – ﹤0.01% 3662
2024
Q3 		$228 Buy
8
+6
+300% +$177 ﹤0.01% 3626
2024
Q2 		$55 Hold
2
– – ﹤0.01% 3681
2024
Q1 		$63 Sell
2
-2
-50% -$73 ﹤0.01% 3446
2023
Q4 		$169 Buy
+4
New +$147 ﹤0.01% 3247

Other funds holding IMVT

HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
TC
Trust Company Manhattan, Kansas $1.11B AUM 13.1% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
GIA
GHP Investment Advisors Denver, Colorado $2.72B AUM 27.58% 1-Year Est. Return

Farther Finance Advisors's IMVT Position: Q2 2026 in Review

Farther Finance Advisors reduced its Immunovant (IMVT) stake by 0.56% in Q2 2026, selling an estimated $427 and leaving 2,472 shares worth $95.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2735.

Farther Finance Advisors first reported a position in IMVT in Q4 2023 and has held it in 11 quarters since. 12 funds tracked by Wall St. Rank hold IMVT as of Q2 2026.

  • Farther Finance Advisors held 2,472 shares of Immunovant worth $95.2K as of Q2 2026.
  • Farther Finance Advisors sold 14 Immunovant shares in Q2 2026, an estimated $427.
  • Immunovant made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #2735 holding.
  • Farther Finance Advisors first reported a position in Immunovant in Q4 2023 and has held it in 11 quarters since.
  • 12 funds tracked by Wall St. Rank held Immunovant as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.